Lonnie O. Ingram

Lonnie O. Ingram

Auto-generated profile, based on publicly available information

Lonnie O. Ingram

Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2007 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
KJKaemwich Jantama
Kaemwich Jantama
MHM.J. Haupt
M.J. Haupt
SSSpyros A. Svoronos
Spyros A. Svoronos
XZXueli Zhang
Xueli Zhang
JMJ.C. Moore
J.C. Moore
LIL.O. Ingram
L.O. Ingram

1 January 2001 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
AMAlfredo Martinez
Alfredo Martinez
MRMaria E. Rodriguez
Maria E. Rodriguez
MWMelissa L. Wells
Melissa L. Wells
SYSean W. York
Sean W. York
JPJames F. Preston
James F. Preston
LILonnie O. Ingram
Lonnie O. Ingram
The hydrolysis of hemicellulose to monomeric sugars by dilute acid hydrolysis is accompanied by the production of inhibitors that retard microbial fermentation. Treatment of hot hydrolysate with Ca(OH)2 (overliming) is an effective method for detoxification. Using ethanologenic Escherichia coli LY01 as the biocatalyst, our results indicate that the optimal lime addition for detoxification varies and depends on the concentration of mineral acids and organic acids in each hydrolysate. This optimum was shown to be readily predicted on the basis of the titration of hydrolysate with 2 N NaOH at ambient temperature to either pH 7.0 or pH 11.0. The average composition of 15 hydrolysates prior to treatment was as follows (per L): 95.24 ± 7.29 g sugar, 5.3 ± 2.99 g acetic acid, 1.305 ± 0.288 g total furans (furfural and hydroxymethylfurfural), and 2.86 ± 0.34 g phenolic compounds. Optimal overliming resulted in a 51 ± 9% reduction of total furans, a 41 ± 6% reduction in phenolic compounds, and a 8.7 ± 4.5% decline in sugar. Acetic acid levels were unchanged. Considering the similarity of microorganisms, it is possible that the titration method described here may also prove useful for detoxification and fermentation processes using other microbial biocatalysts.

1 December 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
XZXueli Zhang
Xueli Zhang
KJKaemwich Jantama
Kaemwich Jantama
JMJonathan C. Moore
Jonathan C. Moore
LJLaura R. Jarboe
Laura R. Jarboe
KSKeelnatham T. Shanmugam
Keelnatham T. Shanmugam
LILonnie O. Ingram
Lonnie O. Ingram
During metabolic evolution to improve succinate production in Escherichia coli strains, significant changes in cellular metabolism were acquired that increased energy efficiency in two respects. The energy-conserving phosphoenolpyruvate (PEP) carboxykinase ( pck ), which normally functions in the reverse direction (gluconeogenesis; glucose repressed) during the oxidative metabolism of organic acids, evolved to become the major carboxylation pathway for succinate production. Both PCK enzyme activity and gene expression levels increased significantly in two stages because of several mutations during the metabolic evolution process. High-level expression of this enzyme-dominated CO 2 fixation and increased ATP yield (1 ATP per oxaloacetate). In addition, the native PEP-dependent phosphotransferase system for glucose uptake was inactivated by a mutation in ptsI . This glucose transport function was replaced by increased expression of the GalP permease ( galP ) and glucokinase ( glk ). Results of deleting individual transport genes confirmed that GalP served as the dominant glucose transporter in evolved strains. Using this alternative transport system would increase the pool of PEP available for redox balance. This change would also increase energy efficiency by eliminating the need to produce additional PEP from pyruvate, a reaction that requires two ATP equivalents. Together, these changes converted the wild-type E. coli fermentation pathway for succinate into a functional equivalent of the native pathway that nature evolved in succinate-producing rumen bacteria.

12 February 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
TCT. B. Causey
T. B. Causey
KSK. T. Shanmugam
K. T. Shanmugam
LYL. P. Yomano
L. P. Yomano
LIL. O. Ingram
L. O. Ingram
Escherichia coli TC44, a derivative of W3110, was engineered for the production of pyruvate from glucose by combining mutations to minimize ATP yield, cell growth, and CO 2 production (Δ atpFH Δ adhE Δ sucA ) with mutations that eliminate acetate production [ poxB :: FRT (FLP recognition target) Δ ackA ] and fermentation products (Δ focA-pflB Δ frdBC Δ ldhA Δ adhE ). In mineral salts medium containing glucose as the sole carbon source, strain TC44(Δ focA-pflB Δ frdBC Δ ldhA Δ atpFH Δ adhE Δ sucA poxB :: FRT Δ ackA ) converted glucose to pyruvate with a yield of 0.75 g of pyruvate per g of glucose (77.9% of theoretical yield; 1.2 g of pyruvate liters –1 ·h –1 ). A maximum of 749 mM pyruvate was produced with excess glucose. Glycolytic flux was >50% faster for TC44 producing pyruvate than for the wild-type W3110 during fully aerobic metabolism. The tolerance of E. coli to such drastic changes in metabolic flow and energy production implies considerable elasticity in permitted pool sizes for key metabolic intermediates such as pyruvate and acetyl-CoA. In strain TC44, pyruvate yield, pyruvate titer, and the rate of pyruvate production in mineral salts medium were equivalent or better than previously reported for other biocatalyts (yeast and bacteria) requiring complex vitamin feeding strategies and complex nutrients. TC44 offers the potential to improve the economics of pyruvate production by reducing the costs of materials, product purification, and waste disposal.

5 September 2000 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
AMAlfredo Martinez
Alfredo Martinez
MRMaria E. Rodriguez
Maria E. Rodriguez
SYSean W. York
Sean W. York
JPJames F. Preston
James F. Preston
LILonnie O. Ingram
Lonnie O. Ingram

4 June 2008 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
KJKaemwich Jantama
Kaemwich Jantama
XZXueli Zhang
Xueli Zhang
JMJ.C. Moore
J.C. Moore
KSK.T. Shanmugam
K.T. Shanmugam
SSS.A. Svoronos
S.A. Svoronos
LIL.O. Ingram
L.O. Ingram